589 related articles for article (PubMed ID: 15250164)
1. [Current aspects in red blood cell substitutes].
Wang Y; Pan J; Yu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Jun; 21(3):490-4. PubMed ID: 15250164
[TBL] [Abstract][Full Text] [Related]
2. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
Kim HW; Greenburg AG
Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
[TBL] [Abstract][Full Text] [Related]
3. Blood substitutes.
Winslow RM
Adv Drug Deliv Rev; 2000 Feb; 40(3):131-42. PubMed ID: 10837785
[TBL] [Abstract][Full Text] [Related]
4. Alternative oxygen therapeutics: products, status of clinical trials, and future prospects.
Winslow RM
Curr Hematol Rep; 2003 Nov; 2(6):503-10. PubMed ID: 14561395
[TBL] [Abstract][Full Text] [Related]
5. Blood substitutes in surgery.
Burris D
Ann Chir Gynaecol; 2001; 90(2):76-80. PubMed ID: 11459262
[TBL] [Abstract][Full Text] [Related]
6. [Current status of researches in the development of blood tissue engineering product].
Li F; Wang J; Yang C
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):972-5. PubMed ID: 18788321
[TBL] [Abstract][Full Text] [Related]
7. The development of hemoglobin solutions as red cell substitutes.
Ogden JE; Parry ES
Int Anesthesiol Clin; 1995; 33(1):115-29. PubMed ID: 7635553
[TBL] [Abstract][Full Text] [Related]
8. The risks of blood transfusions and the shortage of supply leads to the quest for blood substitutes.
Nouwairi NS
AANA J; 2004 Oct; 72(5):359-64. PubMed ID: 15529732
[TBL] [Abstract][Full Text] [Related]
9. Toward 21st century blood component replacement therapeutics: artificial oxygen carriers, platelet substitutes, recombinant clotting factors, and others.
Kim HW; Greenburg AG
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):537-50. PubMed ID: 17090427
[TBL] [Abstract][Full Text] [Related]
10. Oxygen carriers.
Chang TM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1187-90. PubMed ID: 12211412
[TBL] [Abstract][Full Text] [Related]
11. Current status of oxygen carriers ('blood substitutes'): 2006.
Winslow RM
Vox Sang; 2006 Aug; 91(2):102-10. PubMed ID: 16907870
[TBL] [Abstract][Full Text] [Related]
12. Oxygen therapeutics--current concepts.
Hill SE
Can J Anaesth; 2001 Apr; 48(4 Suppl):S32-40. PubMed ID: 11336435
[TBL] [Abstract][Full Text] [Related]
13. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
[TBL] [Abstract][Full Text] [Related]
14. Canadian Red Cross lecture. Current concepts of oxygen-transporting blood substitutes.
Bolin RB
Can J Surg; 1982 Jul; 25(4):422-4. PubMed ID: 7046893
[TBL] [Abstract][Full Text] [Related]
15. Oxygen carriers ("blood substitutes").
Topfer LA; Hailey D
Issues Emerg Health Technol; 2001 Jul; (21):1-6. PubMed ID: 11776287
[TBL] [Abstract][Full Text] [Related]
16. [Development and challenge of modified hemoglobins as red blood cell substitutes].
Lu XL
Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):7-18. PubMed ID: 16572834
[TBL] [Abstract][Full Text] [Related]
17. New transfusion strategies: red cell substitutes.
Winslow RM
Annu Rev Med; 1999; 50():337-53. PubMed ID: 10073282
[TBL] [Abstract][Full Text] [Related]
18. Artificial blood.
Squires JE
Science; 2002 Feb; 295(5557):1002-5. PubMed ID: 11834811
[TBL] [Abstract][Full Text] [Related]
19. Red cell substitutes: hemoglobin solution or fluorocarbon?
Gould SA; Rosen AL; Sehgal LR; Sehgal HL; Rice CL; Moss GS
J Trauma; 1982 Sep; 22(9):736-40. PubMed ID: 7120525
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic properties of hemoglobin vesicles as a substitute for red blood cells.
Taguchi K; Maruyama T; Otagiri M
Drug Metab Rev; 2011 Aug; 43(3):362-73. PubMed ID: 21428698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
